Last updated on July 2019

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease


Brief description of study

The purpose of this study is to characterize the natural history of leukocyte chemotactic factor 2 amyloidotic (ALECT2) disease. In this observational study participants with ALECT2 disease will be enrolled. Participants, who have already reached end-stage renal disease (ESRD), will provide retrospective chart review data and biological specimens at baseline only. Other participants, in addition to retrospective chart review, will be followed prospectively.

Clinical Study Identifier: NCT03774784

Find a site near you

Start Over

Clinical Trial Site

Denver, CO United States
  Connect »

Clinical Trial Site

Houston, TX United States
  Connect »

Clinical Trial Site

San Antonio, TX United States
  Connect »

Clinical Trial Site

Saint George, UT United States
  Connect »

Clinical Trial Site

Tucson, AZ United States
  Connect »

Clinical Trial Site

Boston, MA United States
  Connect »

Clinical Trial Site

Columbus, OH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.